Before biology became digital, with its -omics and big data, there were mostly gels and microscopy images. The peak of image use in biomedical papers was reached at the turn of the century, those became the golden times of Photoshop-assisted data manipulation. To celebrate that period, I selected an example of the British cancer researcher Paul Workman, President and CEO of the huge Institute of Cancer Research (ICR) in London.
Swedish start-up Verigraft received €2.2 Million from European Union, to further develop regenerative medicine technology tainted by research misconduct and patient abuse. The founder of this very company: Suchitra Sumitran-Holgersson. A clinical trial is scheduled based on debunked science of recellurising dead blood vessel grafts.
The following email exchange took place between the academic Editor-in-Chief of an Elsevier subscription journal and a professor of physics and astronomy, who was invited to peer review a clinical trial study on gestational diabetes, his expertise assumed from some obscure “keywords”.
“I fully support Dr Ashutosh Tiwari being permitted to enter the Docent programme of Linköping University. [.. }He is carrying out first-rate research, supervising students, has organised a number of international events on behalf of Linköping University, has an excellent publication record and has recently designed a PhD course for us. […]
Professor Anthony P F Turner PhD, DSc, FRSC”